Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma
Clinical trial NCT02599402 · COMPLETED
Trial details
- NCT number
- NCT02599402
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-20
- Primary completion
- 2020-02-10
- Enrollment
- 533
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.